Boiron Laboratories Private Limited, a under liquidation foreign private limited company, was established on 22 December 2015 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2015FTC271266. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹37.70 Cr and a paid-up capital of ₹37.70 Cr.
It upholds a compliant status. Its leadership includes Prashant Surana (Managing Director), Prajakta Avil Menezes (Irp/Rp/Liquidator), Charles Jean Hugues Deydier (Director). Past directors included Prashant Surana, Ashwini Pundalik Kamble, Yves Georges Jean Marie Groult. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at A-502, Cello Triumph, I. B. Patel Road, Goregaon (East),, Mumbai, Maharashtra, 400063.
U74999MH2015FTC271266
271266
22 December 2015
₹37.70 Cr
₹37.70 Cr
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Boiron Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Surana | Managing Director | 22 Dec 2015 | Current |
| Prajakta Avil Menezes | Irp/Rp/Liquidator | 14 May 2024 | Current |
| Charles Jean Hugues Deydier | Director | 22 Dec 2015 | Current |
| Yves Georges Jean Marie Groult | Director | 12 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Feb 2016 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2019 | Past |
| Pramod Abcsdd | Director | 01 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Boiron Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.69% decrease. The company also saw a substantial fall in profitability, with a 96.36% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Boiron Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Boiron Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Boiron Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boiron Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Prajakta Avil Menezes was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 14 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Boiron Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Boiron Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.
Progress on Yves Georges Jean Marie Groult was appointed as a Director was appointed as a Director on 12 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
Prashant Surana was appointed as a Managing Director was appointed as a Managing Director on 22 Dec 2015 & has been associated with this company since 9 years 11 months . was recorded as a recent event.
The activity Charles Jean Hugues Deydier was appointed as a Director was appointed as a Director on 22 Dec 2015 & has been associated with this company since 9 years 11 months . was completed.
The CIN of Boiron Laboratories Private Limited is U74999MH2015FTC271266.
Boiron Laboratories Private Limited is headquartered at A-502, Cello Triumph, I. B. Patel Road, Goregaon (East),, Mumbai, Maharashtra, 400063.
Boiron Laboratories Private Limited was incorporated on 22 December 2015.
The current directors of Boiron Laboratories Private Limited are
The primary industry of Boiron Laboratories Private Limited is Trade.
Boiron Laboratories Private Limited is unlisted.
The authorized capital of Boiron Laboratories Private Limited is ₹37.70 Cr, and the paid-up capital is ₹37.70 Cr.
The compliance status of Boiron Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX